MAPK3 and neoplasm: ERK1/2 signaling has been verified to have the ability to regulate some members of the Bcl-2 family, which can contribute to tumor cell survival via increasing anti-apoptotic factors and decreasing pro-apoptotic members of Bcl-2 family (16).